Calisti, Fabrizio
Tocco, Michael
Mao, Yongcai
Goldman, Robert
Funding for this research was provided by:
Angelini Pharma S.p.A. and Sumitomo Pharma America, Inc.
Article History
Received: 20 February 2024
Accepted: 1 May 2024
First Online: 18 July 2024
Declarations
:
: All three of the original studies that were pooled in these post-hoc analyses were approved by an institutional review board/ethics committee at each investigational site and both studies conducted in accordance with the International Conference on Harmonization Good Clinical Practice guidelines and with the ethical principles of the Declaration of Helsinki. After a full explanation of the study was provided, written informed consent was obtained from a parent or legal guardian and assent was obtained from each patient. No individual patient data is contained in this manuscript.
: FC is an employee of Angelini Pharma S.p.A. YM is an employee of Sumitomo Pharma America, Inc. MT and RG are former employees of Sumitomo Pharma America, Inc.